Cory Doctorow argues at The Guardian that all, not just publicly funded, pharmaceutical research should be made open access. Many people, he says, agree that all publicly funded research should be available to the public — the main argument being that since the public funded it, they should be able to see the result. But Doctorow goes a step further.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.